Patented multi-dimensional vascular and bone-scanning biometrics that go far beyond conventional authentication — purpose-built for financial institutions, enterprise organisations, and any body demanding the highest standard of identity assurance.
Unlike conventional biometrics that rely on a single data point, our Universal Identity Device™ (U.I.D.™) simultaneously captures and cross-validates up to six distinct biological markers. Vascular networks and bone structure are physiologically unique to each individual and cannot be duplicated, spoofed or stolen the way fingerprints or facial data can.
Near-infrared transducer scanning maps the three-dimensional geometry of subcutaneous vein networks — patterns that remain stable across a lifetime and are invisible to the naked eye.
Proprietary bone-scanning technology adds a further identity dimension — one unaffected by ageing, injury, or environmental exposure, and wholly impossible to replicate externally.
By combining vascular and skeletal readings simultaneously, U.I.D.™ confirms that authentication is performed by a living individual — eliminating spoofing via recordings, prosthetics, or synthetic materials.
The platform embeds in smartphones, IoT sensors, wearables, smartwatches, and palm-sized scanners — enabling deployment anywhere from border checkpoints to hospital gantries.
3D subcutaneous vascular network identification via near-infrared transducer
Structural bone-reference facial mapping beyond surface-level scanning
High-precision iris mapping as one of six linked biometric modality inputs
Bone density characteristics forming an immutable physiological signature
Optional biosensor integration for health state detection alongside identity
Identity data anchored to an immutable distributed ledger authentication layer
Click any patent number to view the full grant record on Google Patents ↗
Any nation's commitment to becoming a leading digital economy — underpinned by robust national digital identity frameworks, smart city initiatives, and a world-class financial services sector — demands identity infrastructure that is both future-ready and unconditionally secure. U.I.D.™ is designed to meet that standard.
Financial institutions could explore replacing SMS OTPs and knowledge-based credentials with vascular biometric payment authorisation — potentially addressing account takeover, social engineering and SIM-swap vulnerabilities in one architectural layer.
Biometric-anchored digital onboarding could potentially accelerate customer identification processes while supporting alignment with applicable anti-money-laundering due diligence requirements — though institutions would need to assess applicability against their own specific regulatory obligations.
U.I.D.™ could potentially support Strong Customer Authentication requirements across open banking and third-party payment integrations — offering a possible path toward meeting applicable payment services regulatory obligations without adding friction to customer journeys.
Sensitive trading systems, treasury operations and client data environments could potentially benefit from biometric access gating — with tamper-evident event logging offering a foundation for regulatory audit trails.
U.I.D.™ is architected with financial regulatory compliance as a key design consideration. Institutions exploring adoption would work closely with our team to assess fit against their own specific regulatory obligations — no deployment should be assumed from the use cases described here.
Identity-aware sensors could potentially be embedded across urban infrastructure touchpoints — with the possibility of enabling more personalised and secure citizen experiences at locations such as transit gantries, community access points and public facilities.
U.I.D.™ could potentially support a truly passwordless model for digital service access — where a single biometric interaction replaces the need to manage, reset or remember credentials across multiple platforms and services.
Biometrically-confirmed commuter data could potentially enable real-time, privacy-preserving flow analytics across public transport networks — offering transport planners richer occupancy intelligence to inform frequency optimisation and congestion planning.
Educational institutions could explore biometric attendance verification as a means of generating more reliable programme effectiveness data — and as a potential tool for rapid contact identification in the event of a public health incident.
Ambitious digital initiatives — from seamless smart city services to autonomous transport to AI-assisted healthcare — ultimately depend on a reliable answer to one question: who is this person, right now? U.I.D.™ is designed to provide that answer, and we welcome conversations with organisations exploring what that could mean in practice.
U.I.D.™ is architecture-agnostic and sector-universal. Whether deployed at a hospital ward, a construction site, a border checkpoint or a banking application, the same patented core technology delivers consistent, high-certainty identity assurance — at the speed Singapore's economy demands.
Securely digitise individual identity for fraud-proof access to digital services and programmes — removing dependence on physical ID cards or login credentials.
Biometric clearance at air, land and sea entry points — dramatically reducing manual passport checks, cutting queue times and flagging persons of interest in real time.
Frictionless, OTP-free transaction authentication for retail and institutional banking — designed to address account takeover fraud while supporting alignment with applicable strong customer authentication regulatory requirements.
Transform office and residential access control into intelligent, biometrically-aware environments — eliminating physical access cards and enabling data-driven building management.
Palm-scan fare payment and access gating across public transport networks — with predictive occupancy analytics to support real-time fleet optimisation for transport operators.
Accurate time-logging, welfare compliance and safety management for construction, manufacturing and logistics workforces — with biometric confirmation replacing swipe cards entirely.
Global e·dentity™ works alongside leading organisations across sectors to develop and deploy next-generation identity solutions. Our partnerships reflect the breadth of industries where U.I.D.™ technology can deliver meaningful impact.
From public healthcare networks to private specialist centres and pharmaceutical supply chains, U.I.D.™ has been designed to bring identity certainty and health intelligence to every point of care — with the potential to reduce administrative errors, strengthen drug inventory controls and support early-warning pandemic detection capabilities.
Public hospitals and primary care facilities could potentially explore U.I.D.™ to enable faster, more reliable authenticated access to patient records — with the aim of reducing misidentification risk and administrative processing time.
With patient consent, private practitioners could gain biometrically-gated access to records and insurance entitlements — potentially reducing paperwork and consultation wait times.
Biometric inventory controls could potentially be applied to medications, controlled substances and vaccine cold-chain management — creating complete, tamper-evident access audit trails aligned with pharmaceutical regulatory compliance requirements.
Chemosensory sensor integration could potentially enable non-invasive detection of respiratory illness markers — providing early-warning signals before symptomatic spread occurs.
Access to intensive care facilities, operating theatres, pharmacies and clinical data systems could be restricted to verified, credentialled staff only — strengthening clinical governance and data security simultaneously.
Global e·dentity™'s biosurveillance capabilities are supported by published research from the London School of Hygiene and Tropical Medicine (LSHTM), examining the identification of asymptomatic individuals during respiratory disease outbreaks — directly relevant to pandemic preparedness frameworks.
This research demonstrates that vascular biometric scanning, combined with chemosensory detection, may identify physiological markers of infection before clinical symptoms manifest — offering health authorities a potential early-intervention capability.
Published: Department of Disease Control, LSHTM — June 2021
Recognised as one of the most innovative and industry-disrupting private technology companies of 2019 — in the company of early-stage cohorts that went on to redefine their sectors globally.
Global e·dentity™ founder Robert Adams presented the intersection of proactive health intelligence and multimodal biometrics to a global TEDx audience, demonstrating real-world cancer detection application.
Honoured by Tech Tribune as a Best Tech Startup of 2019, reflecting the platform's exceptional early traction and its potential to transform identity infrastructure across multiple industries.
Watch how Global e·dentity™'s patented multimodal biometric platform works — and why it represents a fundamentally different approach to identity assurance for governments, financial institutions and enterprise organisations.
Whether you represent a financial institution, enterprise organisation, or any body seeking to strengthen identity assurance and security, our team would welcome a confidential briefing on how U.I.D.™ can address your specific requirements.
